Fingolimod in COVID‐19  Biological: UC‐MSCs, other: placebo  China/COVID‐19  30, all, 18–80  Treatment  Experimental: treatment group: each patient in the fingolimod treatment group was given 0.5 mg of fingolimod orally once daily, for three consecutive days